Latest StemPoint Capital LP Stock Portfolio
StemPoint Capital LP Performance:
2025 Q3: 26.06%YTD: 12.88%2024: 1.93%
Performance for 2025 Q3 is 26.06%, and YTD is 12.88%, and 2024 is 1.93%.
About StemPoint Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $499.1 Millions as of 30 Sep, 2025.
The top stock holdings of STEMPOINT CAPITAL LP are ROIV, QURE, SRRK. The fund has invested 12.7% of it's portfolio in ROIVANT SCIENCES LTD and 6.1% of portfolio in UNIQURE NV.
The fund managers got completely rid off MERUS N V (MRUS), LEGEND BIOTECH CORP and ZAI LAB LTD (ZLAB) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), KALVISTA PHARMACEUTICALS INC (KALV) and MADRIGAL PHARMACEUTICALS INC (MDGL). STEMPOINT CAPITAL LP opened new stock positions in ARGENX SE, REVOLUTION MEDICINES INC (RVMD) and XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to ROIVANT SCIENCES LTD (ROIV), BIOHAVEN LTD and PROTAGONIST THERAPEUTICS INC (PTGX).
The top stock holdings of STEMPOINT CAPITAL LP are ROIV, QURE, SRRK. The fund has invested 12.7% of it's portfolio in ROIVANT SCIENCES LTD and 6.1% of portfolio in UNIQURE NV.
The fund managers got completely rid off MERUS N V (MRUS), LEGEND BIOTECH CORP and ZAI LAB LTD (ZLAB) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), KALVISTA PHARMACEUTICALS INC (KALV) and MADRIGAL PHARMACEUTICALS INC (MDGL). STEMPOINT CAPITAL LP opened new stock positions in ARGENX SE, REVOLUTION MEDICINES INC (RVMD) and XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to ROIVANT SCIENCES LTD (ROIV), BIOHAVEN LTD and PROTAGONIST THERAPEUTICS INC (PTGX).
StemPoint Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that STEMPOINT CAPITAL LP made a return of 26.06% in the last quarter. In trailing 12 months, it's portfolio return was 9.24%.
New Buys
| Ticker | $ Bought |
|---|---|
| argenx se | 9,193,680 |
| revolution medicines inc | 8,657,250 |
| xenon pharmaceuticals inc | 7,720,640 |
| celcuity inc | 6,753,470 |
| dyne therapeutics inc | 6,003,840 |
| jazz pharmaceuticals plc | 5,149,690 |
| avidity biosciences inc | 4,969,290 |
| ocular therapeutix inc | 4,202,200 |
New stocks bought by StemPoint Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| roivant sciences ltd | 597 |
| biohaven ltd | 482 |
| gh research plc | 440 |
| tectonic therapeutic inc | 372 |
| protagonist therapeutics inc | 185 |
| denali therapeutics inc | 145 |
| wave life sciences ltd | 134 |
| bridgebio pharma inc | 133 |
Additions to existing portfolio by StemPoint Capital LP
Reductions
| Ticker | % Reduced |
|---|---|
| arcellx inc | -94.35 |
| kalvista pharmaceuticals inc | -85.32 |
| madrigal pharmaceuticals inc | -84.43 |
| mineralys therapeutics inc | -74.97 |
| protara therapeutics inc | -68.2 |
| rhythm pharmaceuticals inc | -48.26 |
| centessa pharmaceuticals plc | -48.22 |
| mbx biosciences inc | -46.82 |
StemPoint Capital LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| eyepoint pharmaceuticals inc | -3,098,280 |
| helix acquisition corp ii | -3,290,860 |
| legend biotech corp | -9,587,410 |
| merus n v | -13,996,500 |
| zai lab ltd | -8,757,820 |
| lenz therapeutics inc | -5,390,460 |
| janux therapeutics inc | -2,077,450 |
| apogee therapeutics inc | -3,668,360 |
StemPoint Capital LP got rid off the above stocks
Sector Distribution
STEMPOINT CAPITAL LP has about 83.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 83.3 |
| Others | 16.6 |
Market Cap. Distribution
STEMPOINT CAPITAL LP has about 2.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 37.9 |
| SMALL-CAP | 30.6 |
| UNALLOCATED | 17.7 |
| MICRO-CAP | 8.4 |
| NANO-CAP | 2.9 |
| LARGE-CAP | 2.5 |
Stocks belong to which Index?
About 46.3% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53 |
| RUSSELL 2000 | 46.3 |
StemPoint Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of StemPoint Capital LP
STEMPOINT CAPITAL LP has 76 stocks in it's portfolio. About 50.9% of the portfolio is in top 10 stocks. AKRO proved to be the most loss making stock for the portfolio. QURE was the most profitable stock for STEMPOINT CAPITAL LP last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | whitehawk therapeutics inc | 0.16 | 424,082 | 805,756 | new | |||
| ABUS | arbutus biopharma corp | 0.19 | 205,388 | 932,462 | new | |||
| ACLX | arcellx inc | 0.19 | 11,376 | 933,970 | reduced | -94.35 | ||
| ADCT | adc therapeutics sa | 0.23 | 283,286 | 1,133,140 | unchanged | 0.00 | ||
| ADGI | invivyd inc | 0.06 | 278,608 | 306,469 | new | |||
| AKRO | akero therapeutics inc | 1.16 | 121,410 | 5,764,550 | added | 3.97 | ||
| ALKS | alkermes plc | 1.45 | 241,637 | 7,249,110 | reduced | -31.18 | ||
| AMLX | amylyx pharmaceuticals inc | 0.75 | 276,884 | 3,761,970 | new | |||
| ARCT | arcturus therapeutics hldgs | 0.13 | 35,606 | 656,219 | new | |||
| ARQT | arcutis biotherapeutics inc | 1.56 | 411,893 | 7,764,180 | added | 100 | ||
| ASMB | assembly biosciences inc | 0.34 | 66,130 | 1,692,930 | new | |||
| ATAI | atai life sciences nv | 0.08 | 76,032 | 402,209 | new | |||
| BBIO | bridgebio pharma inc | 1.33 | 127,435 | 6,618,970 | added | 133 | ||
| CDTX | cidara therapeutics inc | 2.92 | 152,325 | 14,586,600 | reduced | -42.9 | ||
| CELC | celcuity inc | 1.35 | 136,710 | 6,753,470 | new | |||
| CLPT | clearpoint neuro inc | 0.07 | 16,651 | 362,825 | new | |||
| CMPS | compass pathways plc | 0.32 | 275,620 | 1,579,300 | new | |||
| CNTA | centessa pharmaceuticals plc | 3.18 | 655,385 | 15,893,100 | reduced | -48.22 | ||
| CRVS | corvus pharmaceuticals inc | 0.14 | 96,439 | 710,755 | new | |||
| DNLI | denali therapeutics inc | 5.05 | 1,734,660 | 25,187,200 | added | 145 | ||